Life sciences technology related conferences - Page 3
60 results found
BIT's Annual World Congress of Mariculture and Fisheries
WCMF-2013 with the theme of Promoting Sustainable Fishery Development will be held in Hangzhou, China during September 23-25, 2013. It is intended to provide a platform for professionals around the world to exchange state-of-the-art research and development and identify research needs and opportunities in the field of fisheries. There’re 6 chapters and 40 sessions in the tentative program, which including fishing, breeding, aquaculture, seafood industry, recreational fisheries, and also ...more
The Viral Hepatitis Congress
Building on the success of the 2012 Congress, we aim to provide a relevant, meaningful and topical Scientific Programme reflecting the latest progress and innovations in therapeutic strategies and research in the management of viral hepatitis. The Congress will have a particular focus on developments in the practical aspects of disease management – an important consideration as we draw closer to the era of wider treatment choices and more individualised clinical decisions.
The three Rs Event: Toll like receptors (TLRs),RIG-like receptors (RLRs) and Nod-like receptors (NLR)
The aim of this meeting is to provide an overview of these three families of receptors and provide the most recent advances in the area of innate immune pattern recognitionMeeting chairs: Dr Martha Triantafilou/Professor Kathy Triantafilou, Cardiff University School of Medicine, UK This event has CPD accreditation and will have a troubleshooting panel session. On registration you will be able to submit your questions to the panel that will be asked by the chair on the day of the event ...more
International Conference "Polymers for Advanced Technologies" PAT
Venue: Henry Ford Building, Berlin, Germany
The 12th International Conference Polymers for Advanced Technologies PAT to be held in Berlin (Germany) from 29 September - 02 October 2013.
The annual conference will be accompanied by an extensive, specialized industrial exhibition.
Polymers for Life Sciences
• Drug release systems
• Biomimetic materials
• Degradable polymers and polymers from renewable ressources
• Implantable and injectable materials, including scaffolds and particles
• Polymer ...more
Pseudotype viruses - applications and troubleshooting
Pseudotype viruses are rapidly establishing themselves as important research and diagnostic tools of basic and clinical scientists facilitating the detailed study of individual viral genes, host cell receptors and highly pathogenic viruses, circumventing the need for high-level biosafety containment. The switching of surface envelope proteins expressed on the surface of these pseudotypes enables them to be used as surrogate viruses in neutralization/antiviral screening assays and for the study ...more
Molecular Life Sciences
The GBM announces its upcoming biannual fall meeting 2013 in Frankfurt. We continue with our new tradition to have the meeting at the same venue in Frankfurt to strengthen our corporate identity and establish a prominent recognition factor.
The meeting covers the major aspects of molecular life sciences from a broad range of model systems. Topics covered by distinguished plenary lectures include 'Protein Synthesis and Folding', 'Chemical and Systems Biology', 'Metabolic Sensing', ...more
Analysis of autophagy regulation: Discussion of recent research and new technologies
Meeting Chair: Dr. Gary Warnes, Blizard Institute, Barts & The London School of Medicine & Dentistry, Queen Mary UniversityThis event has CPD accreditation
This meeting will present and discuss current research into autophagy regulation including new flow cytometric and imaging assays and approaches which available to study this regulation
This event is part of the 2013 Flow Cytometry Forum – www.FlowCytometry2013.com
Who Should Attend
Flow cytometry specialists
Biotech and Pharma ...more
Cell Cycle Analysis: the research and the technology
Venue: Cineworld The O2, london, United Kingdom
Meeting Chair: Dr Michael G Ormerod, Consultant, UK
This meeting will present and discuss current research into cell cycle regulation including new approaches available to study this regulation
Who Should Attend
Flow cytometry specialists
Biotech and Pharma Industry: CEOs, Chief Scientists, Group Heads, Senior and Junior Scientists, Research Managers
Academic and Research Institutes: Group and Lab Heads, Postdoctoral Scientists and Research Students
This event is part of the 2013 Flow ...more
Alzheimer Europe Conference
This year, our conference is set under the motto "Living well in a dementia-friendly society". We will explore how our perceptions and image of dementia have an impact on the lives of people with dementia and their carers. We will showcase examples of good practice with regard to the involvement of people with dementia in activities and projects and the establishment of dementia friendly communities. The importance of ethical issues and a rights-based legal framework will also be addressed. By ...more
The Immunology of a successful pregnancy
This event will challenge scientists and clinicians interested in the field of reproductive immunology to evaluate many of the 'classical concepts' associated with pregnancy immunology. This event aims to define new approaches to allow a better understanding of immunity during pregnancy that will benefit mothers and foetuses in different clinical scenarios.
This event has CPD accreditation and is part of the 2013 Pregnancy Summit - www.PregnancySummit2013.com...more
Biomarkers for a successful pregnancy
Successful biomarker profiling in pregnant or prenatal women could not only help predict the pregnancy risk to mothers, but also survival rate of the unborn child and any possible future complications. There is a wide range of possibility for using biomarkers in pregnancy and prenatal testing. For example, research is currently being undertaken to identify biomarkers for
• ectopic pregnancy.
• potential rejection of pregnancy by the mother
• possible cardiovascular issues
Gestational diseases and disorders in pregnancy: prevention, identification, treatment and control
Gestational maternal diseases and disorders, brought on by pregnancy, can impact on maternal and foetal health both during and after pregnancy. This event aims is to look at current research and practice into early identification of disease development and treatment that has low foetal impact.
This event has CPD accreditation and is part of the 2013 Pregnancy Summit
Who Should Attend
Biotech and Pharma Industry : CEOs, Chief Scientists, Group Heads, Senior and Junior ...more
International Conference and Exhibition on Cell & Gene Therapy
Venue: Holiday Inn Orlando International Airport, Orlando, USA
Cell Therapy-2013 is a remarkable event which brings together a unique and International mix of leading Universities and cell therapy institutions making the Congress a perfect platform to share experience and which paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies in emerging cell & gene therapies.
• Cell & Gene Therapy- Potential Applications
• Stem Cell Therapies
• Cellular ...more
International Conference and Exhibition on Probiotics & Functional Foods
OMICS Group is delighted to invite you to attend the 2nd International Conference and Exhibition on Probiotics & Functional Foods during October 23-25, 2013 at Holiday Inn Orlando International Airport, USA.
Probiotics-2013 Conference is encouraging student and young scientist participation as we have Student Poster Award and Young Scientist Challenge Trophy sponsored by ICFMH and B-Crobes.
2nd International Conference and Exhibition on Probiotics & Functional ...more
The Pharma Market Access Pricing and Reimbursement Confererence
The conference will provide attendees with an opportunity to learn about the key developments impacting the future of pharmaceutical pricing and reimbursement, including:
The increasing importance of generating, collecting and analyzing reimbursement evidence early in product development and identifying points of differentiation of a product versus existing standards of care
The impact of Health Technology Assessments (HTAs) on both private and public payer reimbursement decisions